Quoin Pharmaceuticals Ltd...

0.30
0.09 (41.78%)
At close: Apr 02, 2025, 3:59 PM

Quoin Pharmaceuticals Ltd. Statistics

Share Statistics

Quoin Pharmaceuticals Ltd. has 5.05M shares outstanding. The number of shares has increased by 135.73% in one year.

Shares Outstanding 5.05M
Shares Change (YoY) 135.73%
Shares Change (QoQ) 77.2%
Owned by Institutions (%) 0.03%
Shares Floating 4.69M
Failed to Deliver (FTD) Shares 23.81K
FTD / Avg. Volume 0.44%

Short Selling Information

The latest short interest is 19.17K, so 0.35% of the outstanding shares have been sold short.

Short Interest 19.17K
Short % of Shares Out 0.35%
Short % of Float 0.49%
Short Ratio (days to cover) 0.2

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -0.19. Quoin Pharmaceuticals Ltd.'s PEG ratio is 0.

PE Ratio 0
Forward PE -0.19
PS Ratio 0
Forward PS 0
PB Ratio 0
P/FCF Ratio 0
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Quoin Pharmaceuticals Ltd..

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.

Current Ratio 3.57
Quick Ratio 3.57
Debt / Equity 0
Debt / EBITDA -
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-2.99B
Employee Count 3
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -66.29% in the last 52 weeks. The beta is 1.59, so Quoin Pharmaceuticals Ltd.'s price volatility has been higher than the market average.

Beta 1.59
52-Week Price Change -66.29%
50-Day Moving Average 0.31
200-Day Moving Average 0.55
Relative Strength Index (RSI) 49.51
Average Volume (20 Days) 5.46M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income 0
Net Income -8.96B
EBITDA 0
EBIT n/a
Earnings Per Share (EPS) -1911.5
Full Income Statement

Balance Sheet

The company has 3.62B in cash and 0 in debt, giving a net cash position of 3.62B.

Cash & Cash Equivalents 3.62B
Total Debt 0
Net Cash 3.62B
Retained Earnings -55.17B
Total Assets 15.71B
Working Capital 10.75B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.86B and capital expenditures 0, giving a free cash flow of -7.86B.

Operating Cash Flow -7.86B
Capital Expenditures 0
Free Cash Flow -7.86B
FCF Per Share -1675.79
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

QNRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for QNRX is $4, which is 1233.3% higher than the current price. The consensus rating is "Buy".

Price Target $4
Price Target Difference 1233.3%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Apr 8, 2025. It was a backward split with a ratio of 1:20.

Last Split Date Apr 8, 2025
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score -4.1
Piotroski F-Score 1